Medicus Pharma (Medicus Pharma) Retained Earnings : $-19.18 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Medicus Pharma Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Medicus Pharma's retained earnings for the quarter that ended in Dec. 2023 was $-19.18 Mil.

Medicus Pharma's quarterly retained earnings declined from Jun. 2023 ($-13.37 Mil) to Sep. 2023 ($-16.33 Mil) and declined from Sep. 2023 ($-16.33 Mil) to Dec. 2023 ($-19.18 Mil).

Medicus Pharma's annual retained earnings declined from Dec. 2021 ($-10.70 Mil) to Dec. 2022 ($-12.39 Mil) and declined from Dec. 2022 ($-12.39 Mil) to Dec. 2023 ($-19.18 Mil).

Medicus Pharma Retained Earnings Historical Data

The historical data trend for Medicus Pharma's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Pharma Retained Earnings Chart

Medicus Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Retained Earnings

-10.70

-12.39

-19.18

Medicus Pharma Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Retained Earnings	Get a 7-Day Free Trial				-12.39	-12.88	-13.37	-16.33	-19.18

Medicus Pharma Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Medicus Pharma (OTCPK:MDPLF) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Medicus Pharma (Medicus Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (OTCPK:MDPLF) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

MDCX:Canada

Address

100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4

Website

http://www.medicuspharma.com

Medicus Pharma Ltd will carry on the business of pharmaceutical drug development focused initially on SkinJect. The objective of SkinJect is developing and commercializing novel microneedle arrays for the purpose of treating certain skin cancers, initially basal cell carcinoma.

Medicus Pharma (Medicus Pharma) Headlines

From GuruFocus

Medicus Pharma Opens the Market

By PRNewswire • 10-26-2023